Glycolytic Power and Muscle Growth Response to Resistance Training
Official title: HyperLa: Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training: A Multi-centre Study by the HyperLa Study Group
Run by Technical University of Munich · NCT07721766 · Data updated 2026-11-12
The study tests whether a person’s glycolytic efficiency predicts how much their muscles grow after eight weeks of resistance training.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Technical University of Munich Academic / other |
| Locations | 8 sites (Jyväskylä, Central Finland and 7 other locations) |
| Status | Recruiting |
| Started | May 4, 2026 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT07721766 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults with BMI 20-29 kg/m2, no recent resistance training, limited aerobic activity, and no contraindicating medical conditions.
✕Probably not a fit
Individuals with recent structured training history, current cardiovascular or metabolic diseases, or conditions preventing exercise may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter study looks at whether the glycolytic phenotype, measured by the vLapeak lactate peak during a short all-out sprint, can forecast lower-body muscle hypertrophy after an 8-week resistance program. Participants will undergo the vLapeak test, then complete twice-weekly supervised leg-focused training with progressively challenging loads. Muscle size will be assessed with ultrasound before and after training, while blood metabolomics and optional muscle biopsies explore metabolic changes that relate to hypertrophy. The study uses a single-arm design to link metabolic phenotype with physical adaptation in healthy adults.
Why it matters
Potential benefit: If successful, results could support personalized training plans based on metabolic profiles to optimize muscle growth.
How similar studies have gone: Previous work has shown metabolic phenotypes can relate to exercise responses, though this specific vLapeak–hypertrophy link is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Body Mass Index (BMI) between 20-29 kg/m2 * No structured resistance training performed in the last twelve months. * Maximum of four sessions per week of recreational or low-to-moderate aerobic endurance activity. * No history of competitive strength or physique sports. Exclusion Criteria: * Diagnosed cardiovascular, pulmonary, metabolic, neuromuscular, or orthopaedic disease that contraindicates exercise. * Positive response to any question on the PAR-Q 2025 questionnaire. * Current use of anabolic steroids, creatine, or other substances known to strongly influence muscle hypertrophy. * Regular engagement in shift work. * Women who are pregnant or breastfeeding.
Where it's running
-
University of Jyväskylä, Faculty of Sport and Health Sciences
Jyväskylä, Central Finland, Finland Recruiting -
Technical University of Munich, TUM School of Medicine and Health
München, Bavaria, Germany Recruiting -
DLR Cologne, Department of Metabolism and Human Performance
Cologne, North Rhine-Westphalia, Germany Recruiting -
iST University of Applied Sciences
Düsseldorf, North Rhine-Westphalia, Germany Recruiting -
TU Chemnitz, Sports Medicine and Exercise Therapy
Chemnitz, Saxony, Germany Recruiting -
Institute for Applied Training Science (IAT) Leipzig
Leipzig, Saxony, Germany Recruiting
Show 2 more locations
-
University of Limerick, Department of Physical Education and Sport Sciences (PESS)
Limerick, Limerick, Ireland Recruiting -
Universidad Politécnica de Madrid, Facultad de Ciencias de la Actividad Física y del Deporte (INEF)
Madrid, Madrid, Spain Recruiting
Study contacts
- Study coordinator: Henning Wackerhage, Prof. Dr.
- Email: henning.wackerhage@tum.de
- Phone: +49 89 289 24480
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sensation Seeking and TMS Response in TRD: Does Personality Shape Treatment Outcomes?
This real-world study tests whether people with treatment-resistant depression who have higher sensation-seeking traits respond differently to TMS treatment.
-
Exercise phenotyping before chemotherapy in newly diagnosed multiple myeloma
This observational study tests whether some newly diagnosed multiple myeloma patients with normal resting heart function already show limited exercise capacity, and whether that limitation relates to subtle heart tissue changes and future heart-related outcomes.
-
Resistance training to protect muscle during tirzepatide treatment
This study tests whether adding resistance training helps preserve thigh muscle mass in adults with obesity who are taking tirzepatide.
-
Heart heartbeats: using PEG to separate macrotroponin from real troponin elevations
This study tests whether polyethylene glycol precipitation can distinguish macrotroponin from true troponin elevations in people with acute coronary syndrome and in healthy marathon runners.
-
AI-written plain-language discharge summaries for people with blood and other cancers
This project tests whether AI-written plain-language discharge letters help adults with hematologic or other cancers understand their diagnosis, treatment, and next steps better than the usual medical letter.
-
Whole-food, plant-based diet for people with early-stage CLL
See if a 4-week whole-food, plant-based diet changes immune activity and blood counts in people with early-stage, untreated CLL.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.